TR200000054A2 - Klaritromisin içeren sürekli salım sağlayan tablet formülasyonları. - Google Patents

Klaritromisin içeren sürekli salım sağlayan tablet formülasyonları.

Info

Publication number
TR200000054A2
TR200000054A2 TR2000/00054A TR200000054A TR200000054A2 TR 200000054 A2 TR200000054 A2 TR 200000054A2 TR 2000/00054 A TR2000/00054 A TR 2000/00054A TR 200000054 A TR200000054 A TR 200000054A TR 200000054 A2 TR200000054 A2 TR 200000054A2
Authority
TR
Turkey
Prior art keywords
sustained
release
clarithromycin
formulations containing
release tablet
Prior art date
Application number
TR2000/00054A
Other languages
English (en)
Inventor
Öner Levent
Toksöz Ahmet
Original Assignee
Sanovel İlaç San. Ve Ti̇c. Anoni̇m Şi̇rketi̇
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel İlaç San. Ve Ti̇c. Anoni̇m Şi̇rketi̇ filed Critical Sanovel İlaç San. Ve Ti̇c. Anoni̇m Şi̇rketi̇
Priority to TR2000/00054A priority Critical patent/TR200000054A2/tr
Priority to AU36329/01A priority patent/AU3632901A/en
Priority to PCT/TR2001/000002 priority patent/WO2001049246A2/en
Publication of TR200000054A2 publication Critical patent/TR200000054A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

Bu bulus, sürekli salim saglayan matriks materyali olarak hidroksipropilmetilselüloz ve etkin madde oalrak klaritromisin içeren uzun etkili tabletleri kapsar. Klaritromisin, sürekli salim saglayan tabletten Mt/M =ktn ile ifade edilen bir hizla salinir. Burada n salim kinetiklerinin üssüdür ve n degeri salim mekanizmasinin tipini tayin eder. n;0.89 ile 1 arasinda oldugunda salim hizi sifir derece kinetige göre gerçeklesir ve zamandan bagimsizdir.
TR2000/00054A 2000-01-05 2000-01-05 Klaritromisin içeren sürekli salım sağlayan tablet formülasyonları. TR200000054A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2000/00054A TR200000054A2 (tr) 2000-01-05 2000-01-05 Klaritromisin içeren sürekli salım sağlayan tablet formülasyonları.
AU36329/01A AU3632901A (en) 2000-01-05 2001-01-04 Sustained release tablet formulations comprising clarithromycin
PCT/TR2001/000002 WO2001049246A2 (en) 2000-01-05 2001-01-04 Sustained release tablet formulations comprising clarithromycin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2000/00054A TR200000054A2 (tr) 2000-01-05 2000-01-05 Klaritromisin içeren sürekli salım sağlayan tablet formülasyonları.

Publications (1)

Publication Number Publication Date
TR200000054A2 true TR200000054A2 (tr) 2001-08-21

Family

ID=21622322

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00054A TR200000054A2 (tr) 2000-01-05 2000-01-05 Klaritromisin içeren sürekli salım sağlayan tablet formülasyonları.

Country Status (3)

Country Link
AU (1) AU3632901A (tr)
TR (1) TR200000054A2 (tr)
WO (1) WO2001049246A2 (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2288898T3 (es) * 2001-08-13 2008-02-01 Fondazione Salvatore Maugeri - Clinica del Lavoro e della Riabilitazione Uso de composiciones de claritromicina en la fabricacion de un medicamento para el tratamiento de la artritis deformante.
US6642276B2 (en) * 2001-10-01 2003-11-04 M/S Ind-Swift Limited Controlled release macrolide pharmaceutical formulations
WO2005082331A2 (en) * 2004-02-26 2005-09-09 Ranbaxy Laboratories Limited Extended release tablets of clarithromycin
EP2283824B1 (en) 2009-07-30 2017-04-19 Special Products Line S.p.A. Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0967256A (ja) * 1995-08-31 1997-03-11 Taisho Pharmaceut Co Ltd 感冒薬
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
US6010718A (en) * 1997-04-11 2000-01-04 Abbott Laboratories Extended release formulations of erythromycin derivatives
SI20150A (sl) * 1999-02-19 2000-08-31 Lek, Tovarna Farmacevtskih In Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina

Also Published As

Publication number Publication date
WO2001049246A2 (en) 2001-07-12
AU3632901A (en) 2001-07-16
WO2001049246A3 (en) 2002-08-15

Similar Documents

Publication Publication Date Title
NO20016108L (no) Kontrollert frigivelse og smaks maskerende orale farmasöytiske sammensetninger
HUP0101237A1 (hu) Elnyújtott kioldódású gyógyszerkészítmények
MXPA03005096A (es) Composiciones farmaceuticas para el suministro oral de agentes farmacologicamente activos.
AP1954A (en) Controlled release compositions comprising nimesulide.
NO20011471L (no) Nye orale vedvarende frigivelsesformuleringer
NZ507271A (en) Fast disintegrating tablets
NO971206D0 (no) Forlenget-frigjöringsformulering
WO2004112756A8 (en) Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
PT1401501E (pt) Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo
TR200707263T2 (tr) Uzun sürede dışarıya yayılan eritromisin türevi formülleri.
ES2194732T3 (es) Composiciones farmaceuticas orales de liberacion controlada de mesalazina.
NO996349D0 (no) Farmasoeytisk sammensetning som har antitumoraktivitet og/eller reduserte bivirkninger, inneholdende et antitumormiddel og et hydroksimsyrederivat
EP1460998A4 (en) PHARMACEUTICAL TABLET OF METFORMIN WITH PROLONGED RELEASE
ATE252377T1 (de) Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
MXPA05008153A (es) Sistema de encapsulacion de material.
TR200000054A2 (tr) Klaritromisin içeren sürekli salım sağlayan tablet formülasyonları.
MXPA03011317A (es) Comprimido masticable que comprende paracetamol.
TR200102566T2 (tr) Kontrollü salınan betahistin bileşimleri.
NO20010537L (no) Farmasøytiske preparater omfattende ibuprofen og domperidon
MY128759A (en) Oral controlled release formulations
AR013261A1 (es) Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina
FI963567A (fi) Diklofenakki-Na:a sisältävä depottabletti
MXPA01008348A (es) Microcapsulas para la liberacion prolongada de farmacos.
TR200200198T2 (tr) Düşük dozlu tabletler ve hazırlama yöntemi
ATE364403T1 (de) Retardtablette hergestellt aus linearen wasserunlöslichen polysacchariden